Studies of huntingtin localization in human post-mortem brain offer insight
s and a framework for basic experiments in the pathogenesis of Huntington's
disease. In neurons of cortex and striatum, we identified changes in the c
ytoplasmic localization of huntingtin including a marked perinuclear accumu
lation of huntingtin and formation of multivesicular bodies, changes concei
vably pointing to an altered handling of huntingtin in neurons. In Huntingt
on's disease, huntingtin also accumulates in aberrant subcellular compartme
nts such as nuclear and neuritic aggregates co-localized with ubiquitin. Th
e site of protein aggregation is polyglutamine-dependent, both in juvenile-
onset patients having more aggregates in the nucleus and in adult-onset pat
ients presenting more neuritic aggregates. Studies in vitro reveal that the
genesis of these aggregates and cell death are tied to cleavage of mutant
huntingtin. However, we found that the aggregation of mutant huntingtin can
be dissociated from the extent of cell death. Thus properties of mutant hu
ntingtin more subtle than its aggregation, such as its proteolysis and prot
ein interactions that affect vesicle trafficking and nuclear transport, mig
ht suffice to cause neurodegeneration in the striatum and cortex. We propos
e that mutant huntingtin engages multiple pathogenic pathways leading to ne
uronal death.